![](https://endpts.com/wp-content/uploads/2021/04/Greg-Mayes-Antios-tile-scaled.jpg)
CEO Greg Mayes (Antios)
The hunt for a hep B cure heats up, as Antios Therapeutics preps for an IPO
While hepatitis B virus (HBV) infection is avoidable with a vaccine, a host of companies are searching for a cure for the hundreds of thousands …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.